26 Results for "

SHMT

" in MedChemExpress (MCE) Product Catalog:
Products (26)

26 Results for "SHMT" in MCE Product Catalog:

  • Categories Recommended:
    More
Cat. No.: HY-P811867A
Synonyms: SHMT, Glycine hydroxymethyltransferase, Serine methylase, SHMT1

Host:  

Mouse

Application:  

WB, FC

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P88109
Synonyms: GLYA; HEL-S-51e; NEDCASB; SHMT

Host:  

Mouse

Application:  

IHC-P

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P88109A
Synonyms: GLYA; HEL-S-51e; NEDCASB; SHMT

Host:  

Mouse

Application:  

IHC-P

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-177092
CAS No.: 2294820-23-6
AGF347 is a potent and multi-targeted antifolate that targets serine hydroxymethyltransferase (SHMT)2 in the mitochondria and SHMT1 in the cytosol, and inhibits de novo purine biosynthesis. AGF347 induces apoptosis, inhibits mTOR signaling, decreases GSH pools, and increases ROS. AGF347 inhibits proliferation of Cisplatin (HY-17394) sensitive and resistant epithelial ovarian cancer (EOC) cells. AGF347 exhibits antitumor efficacy in SKOV3 EOC xenograft mouse models. AGF347 can be used for ovarian cancer research .
loading...
    loading...
Cat. No.: HY-182284
Anticancer agent 310 is an antitumor agent. Anticancer agent 310 releases nitric oxide to induce mitochondrial ROS burst, triggers mitochondrial dysfunction and activates the Bax/Bcl-2-Cyt c-Caspase-9/Caspase-3 apoptotic pathway. Anticancer agent 310 also reduces the levels of SHMT2 and MTHFD2, decreases the ratios of NADPH/NADP + and GSH/GSSG, thereby disrupting redox homeostasis and exacerbating intracellular ROS accumulation. Anticancer agent 310 can be used in research related to gastric cancer .
loading...
    loading...
Cat. No.: HY-182019
HDAC11-IN-5 is a selective, potent and orally active HDAC11 inhibitor with an IC50 of 0.021 μM. HDAC11-IN-5 increases fatty acylation levels of substrate SHMT2 in AML cells. HDAC11-IN-5 induces apoptosis, G1 phase cell cycle arrest, ferroptosis, ROS production and terminal myeloid differentiation in AML cells. HDAC11-IN-5 demonstrates anti-tumor potency in an MLL-AF9-induced mouse AML model. HDAC11-IN-5 can be used for the research of cancer, such as acute myeloid leukemia .
loading...
    loading...